Comparison of Cadmium Zinc Telluride ECG-gated SPECT equilibrium radionuclide angiocardiography to magnetic resonance imaging to measure right ventricular volumes and ejection fraction in patients with cardiomyopathy.
Cadmium Zinc Telluride ECG-gated SPECT equilibrium radionuclide angiocardiography
Cardiac magnetic resonance imaging
Right ventricle
Journal
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
ISSN: 1532-6551
Titre abrégé: J Nucl Cardiol
Pays: United States
ID NLM: 9423534
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
23
10
2020
accepted:
13
04
2021
pubmed:
15
5
2021
medline:
5
8
2022
entrez:
14
5
2021
Statut:
ppublish
Résumé
The objective of this study was to determine the accuracy of right ventricular function (RVF) assessed by Cadmium Zinc Telluride ECG-gated SPECT equilibrium radionuclide angiocardiography (CZT-ERNA). Twenty-one consecutive patients with cardiomyopathy (aged 54 ± 19 years; 62% male) were included. RV ejection fraction (EF) and volumes were analyzed by CZT-ERNA and compared with values obtained by cardiac magnetic resonance imaging (CMR). Mean values were not different between CZT-ERNA and MRI for RVEF (48.1 ± 10.4% vs 50.8 ± 10.0%; P = .23). Significant correlations (P < .0001) were observed between CZT-ERNA and MRI for RVEF, RV end-diastolic volume, and end-systolic volume (r = 0.81, r = 0.93, and r = 0.96, respectively). Bland-Altman analysis showed a mean difference (bias) between CZT-ERNA and MRI for RVEF of -2.69% (95% CI - 5.35 to - 0.42) with good agreement between the 2 techniques (limits of agreement, -14.3 to 8.99). Intraobserver and interobserver reproducibility of RVF measured by CZT-ERNA was high. CZT-ERNA provides accurate, reproducible assessment of RVF and appears as a good alternative to cardiac magnetic resonance for the evaluation of the magnitude of RVF in patients with cardiomyopathy.
Identifiants
pubmed: 33988809
doi: 10.1007/s12350-021-02653-3
pii: 10.1007/s12350-021-02653-3
doi:
Substances chimiques
Cadmium
00BH33GNGH
Zinc
J41CSQ7QDS
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1647-1656Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021. American Society of Nuclear Cardiology.
Références
De Groote P, Fertin M, Goéminne C, Petyt G, Peyrot S, Foucher-Hossein C, et al. Right ventricular systolic function for risk stratification in patients with stable left ventricular systolic dysfunction: comparison of radionuclide angiography to echoDoppler parameters. Eur Heart J 2012;33:2672-9.
doi: 10.1093/eurheartj/ehs080
Lund LH, Matthews J, Aaronson K. Patient selection for left ventricular assist devices. Eur J Heart Fail 2010;12:434-43.
doi: 10.1093/eurjhf/hfq006
Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010;139:1316-24.
doi: 10.1016/j.jtcvs.2009.11.020
Aissaoui N, Salem J-E, Paluszkiewicz L, Morshuis M, Guerot E, Gorria GM, et al. Assessment of right ventricular dysfunction predictors before the implantation of a left ventricular assist device in end-stage heart failure patients using echocardiographic measures (ARVADE): Combination of left and right ventricular echocardiographic variables. Arch Cardiovasc Dis. 2015;108:3009.
doi: 10.1016/j.acvd.2015.01.011
Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score. J Am Coll Cardiol. Juin 2008;51:2163-72.
doi: 10.1016/j.jacc.2008.03.009
Kavarana MN, Pessin-Minsley MS, Urtecho J, Catanese KA, Flannery M, Oz MC, et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: A continuing problem. Ann Thorac Surg 2002;73:745-50.
doi: 10.1016/S0003-4975(01)03406-3
Lampert BC, Teuteberg JJ. Right ventricular failure after left ventricular assist devices. J Heart Lung Transplant 2015;34:1123-30.
doi: 10.1016/j.healun.2015.06.015
Haddad F, Spruijt OA, Denault AY, Mercier O, Brunner N, Furman D, et al. Right heart score for predicting outcome in idiopathic, familial, or drug- and toxin-associated pulmonary arterial hypertension. JACC Cardiovasc Imaging 2015;8:627-38.
doi: 10.1016/j.jcmg.2014.12.029
France AJ, Prescott RJ, Biernacki W, Muir AL, MacNee W. Does right ventricular function predict survival in patients with chronic obstructive lung disease? Thorax 1988;43:621-6.
doi: 10.1136/thx.43.8.621
Galea N, Carbone I, Cannata D, Cannavale G, Conti B, Galea R, et al. Right ventricular cardiovascular magnetic resonance imaging: normal anatomy and spectrum of pathological findings. Insights Imaging 2013;4:213-23.
doi: 10.1007/s13244-013-0222-3
Grothues F, Moon JC, Bellenger NG, Smith GS, Klein HU, Pennell DJ. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J 2004;147:218-23.
doi: 10.1016/j.ahj.2003.10.005
Couto M, Souto M, Martínez A, Maceira A, Vieira C, Pumar JM, et al. Accuracy of right ventricular volume and function assessed with cardiovascular magnetic resonance: comparison with echocardiographic parameters. Clin Imaging 2020;59:61-7.
doi: 10.1016/j.clinimag.2019.10.002
Marcu CB, Beek AM, Van Rossum AC. Cardiovascular magnetic resonance imaging for the assessment of right heart involvement in cardiac and pulmonary disease. Heart Lung Circ 2006;15:362-70.
doi: 10.1016/j.hlc.2006.08.003
Lairez O, Delmas C, Fournier P, Cassol E, Méjean S, Pascal P, et al. Feasibility and accuracy of gated blood pool SPECT equilibrium radionuclide ventriculography for the assessment of left and right ventricular volumes and function in patients with left ventricular assist devices. J Nucl Cardiol 2018;25:625-34.
doi: 10.1007/s12350-016-0670-5
Mariano-Goulart D, Piot C, Boudousq V, Raczka F, Comte F, Eberlé MC, et al. Routine measurements of left and right ventricular output by gated blood pool emission tomography in comparison with thermodilution measurements: A preliminary study. Eur J Nucl Med 2001;28:506-13.
doi: 10.1007/s002590100497
Mariano-Goulart D, Dechaux L, Rouzet F, Barbotte E, de Kerleau C, Rossi M, et al. Diagnosis of diffuse and localized arrhythmogenic right ventricular dysplasia by gated blood-pool SPECT. J Nucl Med 2007;48:1416-23.
doi: 10.2967/jnumed.107.041129
Nichols K, Saouaf R, Ababneh AA, et al. Validation of SPECT equilibrium radionuclide angiographic right ventricular parameters by cardiac magnetic resonance imaging. J Nucl Cardiol 2002;9:153-60.
doi: 10.1067/mnc.2002.119464
Palyo RJ, Sinusas AJ, Liu Y-H. High-sensitivity and high-resolution SPECT/CT systems provide substantial dose reduction without compromising quantitative precision for assessment of myocardial perfusion and function. J Nucl Med 2016;57:893-9.
doi: 10.2967/jnumed.115.164632
Chen YC, Ko CL, Yen RF, Lo MF, Huang YH, Hsu PY, et al. Comparison of biventricular ejection fractions using cadmium-zinc-telluride SPECT and planar equilibrium radionuclide angiography. J Nucl Cardiol 2016;23:348-61.
doi: 10.1007/s12350-015-0367-1
Haarmark C, Haase C, Jensen MM, Zerahn B. Pre-chemotherapy values for left and right ventricular volumes and ejection fraction by gated tomographic radionuclide angiography using a cadmium-zinc-telluride detector gamma camera. J Nucl Cardiol 2016;23:87-97.
doi: 10.1007/s12350-015-0177-5
Rydberg J, Andersen J, Haarmark C, Zerahn B. The influence of anthropometric and basic circulatory variables on count rate in cadmium-zinc-telluride SPECT gated radionuclide angiography. J Nucl Cardiol 2019;26:1974-80.
doi: 10.1007/s12350-018-1402-9
Tissot H, Roch V, Morel O, Veran N, Perrin M, Claudin M, Verger A, Karcher G, Marie PY, Imbert L. Left ventricular ejection fraction determined with the simulation of a very low-dose CZT-SPECT protocol and an additional count-calibration on planar radionuclide angiographic data. J Nucl Cardiol 2019;26:1539-49.
doi: 10.1007/s12350-019-01619-w
Radiation dose to patients from radiopharmaceuticals (Addendum to ICRP Publication 53). Ann ICRP; 1998.
Anderson K, Prylutska H, Ducharme A, Finnerty V, Grégoire J, Marcotte F, et al. Evaluation of the right ventricle: Comparison of gated blood-pool single photon electron computed tomography and echocardiography with cardiac magnetic resonance. Int J Cardiol 2014;171:1-8.
doi: 10.1016/j.ijcard.2013.11.031
Wells RG, Marvin B, Kovalski G, Ruddy TD. Planar radionuclide angiography with a dedicated cardiac SPECT camera. J Nucl Cardiol 2013;20:358-66.
doi: 10.1007/s12350-013-9674-6
Jensen MM, Schmidt U, Huang C, Zerahn B. Gated tomographic radionuclide angiography using cadmium-zinc-telluride detector gamma camera; comparison to traditional gamma cameras. J Nucl Cardiol 2014;21:384-96.
doi: 10.1007/s12350-013-9844-6
Jensen MM, Haase C, Zerahn B. Interstudy repeatability of left and right ventricular volume estimations by serial-gated tomographic radionuclide angiographies using a cadmium-zinc-telluride detector gamma camera. Clin Physiol Funct Imaging 2015;35:418-24.
doi: 10.1111/cpf.12178
Duvall WL, Guma-Demers KA, George T, Henzlova MJ. Radiation reduction and faster acquisition times with SPECT gated blood pool scans using a high-efficiency cardiac SPECT camera. J Nucl Cardiol 2016;23:1128-38.
doi: 10.1007/s12350-015-0214-4
Hansen NL, Haarmark C, Zerahn B. Ventricular peak emptying and filling rates measured by gated tomographic radionuclide angiography using a cadmium-zinc-telluride SPECT camera in chemotherapy-naïve cancer patients. J Nucl Cardiol 2020;27:1193-201.
doi: 10.1007/s12350-019-01756-2
Kjaer A, Lebech AM, Hesse B, Petersen CL. Right-sided cardiac function in healthy volunteers measured by first-pass radionuclide ventriculography and gated blood-pool SPECT: Comparison with cine MRI. Clin Physiol Funct Imaging. 2005;25:344-9.
doi: 10.1111/j.1475-097X.2005.00635.x
Guazzi M, Villani S, Generati G, Ferraro OE, Pellegrino M, Alfonzetti E, et al. Right ventricular contractile reserve and pulmonary circulation uncoupling during exercise challenge in heart failure: pathophysiology and clinical phenotypes. JACC Heart Fail 2016;4:625-35.
doi: 10.1016/j.jchf.2016.03.007